AR100620A1 - ADDITION SALTS OF (S) -2- (1- (6-AMINO-5-CYANOPIRIMIDIN-4-ILAMINO) ETIL) -4-OXO-3-PHENYL-3,4-DIHYDROPIRROLO [1,2-F] [ 1,2,4] TRIAZINE-5-CARBONITRILE - Google Patents

ADDITION SALTS OF (S) -2- (1- (6-AMINO-5-CYANOPIRIMIDIN-4-ILAMINO) ETIL) -4-OXO-3-PHENYL-3,4-DIHYDROPIRROLO [1,2-F] [ 1,2,4] TRIAZINE-5-CARBONITRILE

Info

Publication number
AR100620A1
AR100620A1 ARP150101656A ARP150101656A AR100620A1 AR 100620 A1 AR100620 A1 AR 100620A1 AR P150101656 A ARP150101656 A AR P150101656A AR P150101656 A ARP150101656 A AR P150101656A AR 100620 A1 AR100620 A1 AR 100620A1
Authority
AR
Argentina
Prior art keywords
carbonitrile
triazine
oxo
phenyl
amino
Prior art date
Application number
ARP150101656A
Other languages
Spanish (es)
Inventor
Carme Serra Coma Maria
Sanchez Izquierdo Francisco
Vidal Juan Bernat
Bautista Perez Garcia Juan
Carrera Carrera Francesc
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of AR100620A1 publication Critical patent/AR100620A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Abstract

Sales de adición, farmacéuticamente aceptables, de (S)-2-(1-(6-amino-5-cianopirimidin-4-ilamino)etil)-4-oxo-3-fenil-3,4-dihidropirrolo[1,2-f][1,2,4]triazina-5-carbonitrilo con derivados de acido sulfónico, en particular con ácido metanosulfónico, ácido naftaleno-2-sulfónico y ácido para-toluenosulfónico, y a los solvatos farmacéuticamente aceptables de las mismas, y su uso como inhibidores de Fosfoinosítido 3-quinasa (Pl3K).Pharmaceutically acceptable addition salts of (S) -2- (1- (6-amino-5-cyanopyrimidin-4-ylamino) ethyl) -4-oxo-3-phenyl-3,4-dihydropyrrolo [1,2 -f] [1,2,4] triazine-5-carbonitrile with sulfonic acid derivatives, in particular with methanesulfonic acid, naphthalene-2-sulfonic acid and para-toluenesulfonic acid, and to the pharmaceutically acceptable solvates thereof, and their use as phosphinosinoside 3-kinase inhibitors (Pl3K).

ARP150101656A 2014-05-27 2015-05-27 ADDITION SALTS OF (S) -2- (1- (6-AMINO-5-CYANOPIRIMIDIN-4-ILAMINO) ETIL) -4-OXO-3-PHENYL-3,4-DIHYDROPIRROLO [1,2-F] [ 1,2,4] TRIAZINE-5-CARBONITRILE AR100620A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14382192 2014-05-27

Publications (1)

Publication Number Publication Date
AR100620A1 true AR100620A1 (en) 2016-10-19

Family

ID=50828850

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP150101656A AR100620A1 (en) 2014-05-27 2015-05-27 ADDITION SALTS OF (S) -2- (1- (6-AMINO-5-CYANOPIRIMIDIN-4-ILAMINO) ETIL) -4-OXO-3-PHENYL-3,4-DIHYDROPIRROLO [1,2-F] [ 1,2,4] TRIAZINE-5-CARBONITRILE
ARP150101655A AR100619A1 (en) 2014-05-27 2015-05-27 PHARMACEUTICAL COMPOSITION THAT COMBINES 3-QUINASA D PHOSFOINOSITE INHIBITORS AND CORTICOESTEROIDS FOR THE TREATMENT OF IMMUNOAMPOLOUS CUTANEOUS DISEASES

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP150101655A AR100619A1 (en) 2014-05-27 2015-05-27 PHARMACEUTICAL COMPOSITION THAT COMBINES 3-QUINASA D PHOSFOINOSITE INHIBITORS AND CORTICOESTEROIDS FOR THE TREATMENT OF IMMUNOAMPOLOUS CUTANEOUS DISEASES

Country Status (1)

Country Link
AR (2) AR100620A1 (en)

Also Published As

Publication number Publication date
AR100619A1 (en) 2016-10-19

Similar Documents

Publication Publication Date Title
UY36152A (en) ADDITION SALTS OF (S) -2- (1- (6-AMINO-5-CYANOPIRIMIDIN-4-ILAMINO) ETIL) -4-OXO-3-PHENYL-3,4-DIHYDROPIRROLO [1,2-F] [ 1,2,4] TRIAZINE-5-CARBONITRILE
CY1121413T1 (en) DIHYDROPYRROLOPYRIDINE ROR-GAMMA INHIBITORS
GT201400196A (en) HETEROCICLYL COMPOUNDS
CR20140460A (en) POLYMODIC FORMS OF (S) -2- (1- (9H-PURIN-6-ILAMINO) PROPIL) -5-FLUORO-3-PHENYLQUINAZOLIN-4 (3H) -ONA
CR20150524A (en) HETEROARILO COMPOUNDS AND ITS USES
ECSP15043696A (en) HETEROARYL COMPOUNDS AND THEIR USES
UY34220A (en) INDAZOLS, PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME
UY36265A (en) “PIRROLO DERIVATIVES [2,3-D] PYRIMIDINE”.
CL2016001973A1 (en) Nucleoside derivatives substituted with 4'-difluoromethyl as inhibitors of influenza arn replication.
UY34104A (en) ? HETEROCYCLIC BENZAMID DERIVATIVE COMPOUNDS, PROCESSES AND INTERMEDIATES FOR PREPARATION, COMPOSITIONS AND METHODS FOR USE.
CO2017002160A2 (en) Optionally condensed heterocyclyl substituted pyrimidine derivatives useful for the treatment of inflammatory, metabolic, oncological and autoimmune diseases
CL2017003107A1 (en) 2- (Pyrazolopyridin-3-yl) pyrimidine derivatives as jak inhibitors
DOP2014000036A (en) PIRIDAZINONE COMPOUNDS AND ITS USE AS DAAO INHIBITORS
UY33885A (en) INHIBITION OF IL17 AND IFN-GAMMA FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATIONS
UY34018A (en) GLUCOSIDE DERIVATIVES AND USES OF THE SAME
AR102981A1 (en) INHIBITORS OF CELL NECROSIS AND METHODS OF PREPARATION OF THE SAME
CO2017002506A2 (en) New activators of soluble guanylate cyclase and their use
DOP2019000290A (en) KINASE INHIBITORS AND USES OF THEM
ECSP18074962A (en) AMINOTIAZOLE DERIVATIVES USEFUL AS ANTITIVIRAL AGENTS
AR101414A1 (en) PIRROLIDINONE DERIVATIVES AS METAP-2 INHIBITORS
UY36110A (en) QUINASE INHIBITORS RELATED TO TROPOMIOSINE
CO2020007044A2 (en) Pyrrole derivatives as inhibitors of acc
UY35876A (en) DERIVATIVES OF PIRAZOLOPIRIMIDIN-2-ILO AS JAK INHIBITORS
AR099766A1 (en) INHIBITORS OF KINASE ASSOCIATED WITH ADAPTER 1, COMPOSITIONS THAT INCLUDE THEM AND METHODS TO USE THEM
CO2019008110A2 (en) Nrf2 trigger

Legal Events

Date Code Title Description
FB Suspension of granting procedure